Elevation Oncology, Inc.
888 Seventh Avenue, 12th Floor
New York, NY 10106
June 24, 2021
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Attention:
| Christopher Edwards Deanna Virginio Gary Newberry Kevin Kuhar |
Re: | Elevation Oncology, Inc. Registration Statement on Form S-1 (File No. 333-256787) originally filed June 4, 2021, as amended, and corresponding Registration Statement on Form 8-A (File No. 001-40523) filed June 21, 2021 |
Requested Date: June 24, 2021
Requested Time: 4:30 PM Eastern Time
Ladies and Gentlemen:
Elevation Oncology, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to declare the above-captioned Registration Statements on Form S-1 and Form 8-A effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.
The Registrant hereby authorizes Robert A. Freedman or Julia Forbess, both of whom are attorneys with the Registrant’s outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration.
The Registrant requests that it be notified of such effectiveness by a telephone call to Mr. Freedman at (650) 335-7292 or, in his absence, Ms. Forbess at (415) 875-2420.
* * *
Sincerely, | ||
Elevation Oncology, Inc. | ||
By: | /s/ Shawn Leland | |
Shawn Leland, Pharm. D., R.Ph. | ||
President and Chief Executive Officer |
cc: | Effie Toshav, Esq. |
Robert A. Freedman, Esq. | |
Julia Forbess, Esq. | |
Fenwick & West LLP |
[Signature Page to Company Acceleration Request Letter]